4//SEC Filing
MABVAX THERAPEUTICS HOLDINGS, INC. 4
Accession 0001209191-15-032499
CIK 0001109196operating
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 7:52 PM ET
Size
8.0 KB
Accession
0001209191-15-032499
Insider Transaction Report
Form 4
WICK MICHAEL M
DirectorPresident, CEO and Chairman
Transactions
- Award
Option to Buy Common Stock
2015-04-02$2.30/sh+34,250$78,775→ 34,250 totalExercise: $2.30Exp: 2025-04-02→ Common Stock (34,250 underlying) - Award
Restricted Stock Unit
2015-04-02+34,250→ 34,250 total→ Common Stock (34,250 underlying)
Footnotes (3)
- [F1]Option vests and becomes exercisable over 3 years from the date of grant, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date.
- [F2]Each restricted stock unit is the economic equivalent of one share of common stock of the Company.
- [F3]Restricted Stock Units vest over 3 years from the date of grant, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date.
Documents
Issuer
MABVAX THERAPEUTICS HOLDINGS, INC.
CIK 0001109196
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001109196
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 7:52 PM ET
- Size
- 8.0 KB